Stockscreener 앱 받기
181.65
2.32%
-4.31
시간 외 거래:
179.03
-2.62
-1.44%
전일 마감가:
$185.96
열려 있는:
$188.21
하루 거래량:
289.91K
Relative Volume:
1.32
시가총액:
$3.58B
수익:
$152.42M
순이익/손실:
$45.24M
주가수익비율:
72.37
EPS:
2.51
순현금흐름:
$6.97M
1주 성능:
-5.24%
1개월 성능:
-12.17%
6개월 성능:
+18.97%
1년 성능:
+63.08%
1일 변동 폭
$180.24
$191.47
1주일 범위
$179.20
$197.00
52주 변동 폭
$93.58
$212.49
리간드 파마 Stock (LGND) Company Profile
명칭
Ligand Pharmaceuticals Inc
전화
858-550-7500
주소
3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA
Compare LGND vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LGND
Ligand Pharmaceuticals Inc
|
181.65 | 3.66B | 152.42M | 45.24M | 6.97M | 2.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
리간드 파마 Stock (LGND) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Citigroup | Buy |
| 2025-04-10 | 개시 | Stifel | Buy |
| 2024-10-03 | 개시 | Oppenheimer | Outperform |
| 2024-07-30 | 개시 | RBC Capital Mkts | Outperform |
| 2021-04-14 | 재개 | Stephens | Overweight |
| 2021-02-04 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-06 | 개시 | Barclays | Overweight |
| 2020-03-24 | 다운그레이드 | Argus | Buy → Hold |
| 2020-03-10 | 개시 | Guggenheim | Neutral |
| 2020-02-06 | 개시 | The Benchmark Company | Buy |
| 2019-09-19 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2019-06-11 | 개시 | Barclays | Equal Weight |
| 2019-05-03 | 재확인 | H.C. Wainwright | Buy |
| 2019-03-06 | 재확인 | H.C. Wainwright | Buy |
| 2018-10-29 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2018-10-02 | 재확인 | H.C. Wainwright | Buy |
| 2018-09-11 | 재확인 | Argus | Buy |
| 2018-08-17 | 개시 | Goldman | Neutral |
| 2018-08-08 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2018-06-21 | 개시 | Argus | Buy |
| 2017-12-27 | 재확인 | H.C. Wainwright | Buy |
| 2017-09-05 | 재개 | H.C. Wainwright | Buy |
| 2016-10-05 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-05 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2016-03-11 | 개시 | Sidoti | Buy |
| 2016-03-03 | 개시 | H.C. Wainwright | Buy |
모두보기
리간드 파마 주식(LGND)의 최신 뉴스
Ligand Pharmaceuticals Announces Fourth Quarter and Full Year 2025 Financial Results Call Scheduled for February 26, 2026 - Quiver Quantitative
Biopharma company Ligand to reveal 2025 results Feb. 26 - Stock Titan
Impax Asset Management Group plc Sells 60,000 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Is Ligand Pharmaceuticals Incorporated in a long term uptrendWeekly Trade Review & Expert Approved Trade Ideas - mfd.ru
Principal Financial Group Inc. Sells 7,210 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Trend Review: Is AMRN a cyclical or defensive stockQuarterly Trade Report & Safe Capital Investment Plans - baoquankhu1.vn
Ranger Investment Management L.P. Has $48.77 Million Stake in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), AbbVie (ABBV) and Bio-Techne (TECH) - The Globe and Mail
Ligand Pharmaceuticals (LGND) director sells $91k in stock By Investing.com - Investing.com India
Ligand Pharmaceuticals (LGND) director sells $91k in stock - Investing.com
Insider Sell: John Kozarich Sells Shares of Ligand Pharmaceutica - GuruFocus
Ligand Pharmaceuticals (LGND) Valuation Check As Partner Milestones Expand Royalty And Growth Potential - simplywall.st
Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - Yahoo Finance
LGND: New Year Program Updates - Zacks Small Cap Research
Villere ST Denis J & Co. LLC Has $49.59 Million Stock Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
New York State Common Retirement Fund Decreases Stock Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Growth Value: Whats next for Global Business Travel Group Inc stockBuy Signal & Weekly High Potential Stock Alerts - baoquankhu1.vn
Earnings Update: Should you avoid IKNA stock right nowJuly 2025 Pullbacks & Technical Pattern Alert System - baoquankhu1.vn
Published on: 2026-02-02 03:00:22 - baoquankhu1.vn
Lisanti Capital Growth LLC Boosts Holdings in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Surprises Report: Can TZOO weather a recessionIndex Update & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Acuitas Investments LLC Purchases 382,597 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Whale Trades: What is the dividend yield of Ligand Pharmaceuticals IncorporatedJuly 2025 Pullbacks & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Can Ligand Pharmaceuticals Incorporated outperform in the next rallyWeekly Stock Report & Entry Point Confirmation Signals - mfd.ru
Breakout Watch: Whats the profit margin of Ligand Pharmaceuticals IncorporatedMarket Rally & AI Driven Stock Movement Reports - baoquankhu1.vn
7,200 Shares in Ligand Pharmaceuticals Incorporated $LGND Acquired by Pier 88 Investment Partners LLC - MarketBeat
Is Ligand Pharmaceuticals Incorporated in a bullish channelBull Run & AI Enhanced Execution Alerts - mfd.ru
Aug Opening: Can KRUS benefit from deglobalizationJuly 2025 Summary & Low Risk Growth Stock Ideas - baoquankhu1.vn
Pullback Watch: Is Ligand Pharmaceuticals Incorporated a stock for growth or value investors2025 Pullback Review & Capital Efficiency Focused Ideas - baoquankhu1.vn
Massachusetts Financial Services Co. MA Buys 202,103 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Stephens Investment Management Group LLC Sells 50,271 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
SG Americas Securities LLC Has $2.08 Million Stock Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Could Be 37% Below Their Intrinsic Value Estimate - Yahoo Finance UK
Travere, Ligand Hammered On A Surprise Delay For Their Linchpin Drug - Investor's Business Daily
Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13 - TechStock²
Ligand Pharmaceuticals (NASDAQ:LGND) Shares Gap DownShould You Sell? - MarketBeat
Patterns Watch: Can Ligand Pharmaceuticals Incorporated stock continue upward trendJuly 2025 Breakouts & Safe Capital Growth Plans - Bộ Nội Vụ
Published on: 2026-01-13 22:28:13 - Bộ Nội Vụ
Gamble on Huge Gains with These 3 Best Biotech Stocks to Buy for 2026 - Yahoo Finance
Can Ligand Pharmaceuticals Incorporated stock rebound after recent weaknessJuly 2025 Fed Impact & Safe Entry Zone Tips - Улправда
Will Ligand Pharmaceuticals Incorporated stock remain a Wall Street favoriteTrade Risk Assessment & Daily Risk Controlled Trade Plans - Улправда
What technical signals suggest for Ligand Pharmaceuticals Incorporated stockJuly 2025 EndofMonth & High Win Rate Trade Tips - Улправда
Is Ligand Pharmaceuticals Incorporated stock attractive for hedge fundsQuarterly Trade Report & Entry Point Confirmation Signals - ulpravda.ru
Is Ligand Pharmaceuticals Incorporated stock a top momentum playExit Point & Free Long-Term Investment Growth Plans - Улправда
Is Ligand Pharmaceuticals Incorporated (LGDN) stock positioned for digital growth eraMarket Performance Summary & Weekly High Return Opportunities - Улправда
Is Ligand Pharmaceuticals Incorporated stock positioned well for digital economyJuly 2025 Snapshot & Weekly Setup with High ROI Potential - Улправда
Risk Recap: How Ligand Pharmaceuticals Incorporated stock reacts to oil pricesMarket Trend Review & Verified Stock Trade Ideas - Улправда
Ligand Pharmaceuticals director Kozarich sells $88,532 in stock By Investing.com - Investing.com South Africa
Book value per share of Ligand Pharmaceuticals Incorporated – OTC:LGNYZ - TradingView — Track All Markets
Ligand Pharmaceuticals director Kozarich sells $88,532 in stock - Investing.com
리간드 파마 (LGND) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.24%
0.19%
자본화:
|
볼륨(24시간):